Innovations in Insulin

Slides:



Advertisements
Similar presentations
Medications Insulin. Without Insulin With Treatment of Insulin.
Advertisements

In-Patient Management of Hyperglycemia Rey Vivo, MD Assistant Professor of Medicine Texas Tech University Health Sciences Center.
Diabetes & Insulin Pens Prepared by: Alison Deux, 4 th year pharmacy student.
T HE I NS AND O UTS OF I NSULIN Mary Beth Wald, RN,BSN,CDE.
Canadian Diabetes Association Clinical Practice Guidelines Pharmacologic Management of Type 2 Diabetes Chapter 13 William Harper, Maureen Clement, Ronald.
1 INTENSIVE INSULIN THERAPY J. Robin Conway M.D. Diabetes Clinic, Smiths Falls, ON
Chris Harrold SpR Diabetes & Endocrinology.  Diabetes is common  15% of all inpatients  50% of those are on insulin  20% of patients experienced an.
Insulin Diabetes Outreach (June 2011). 2 Insulin Learning outcomes >Understand the difference between insulin therapy in type 1 diabetes as compared to.
Canadian Diabetes Assocaition Clinical Practice Guidelines Pharmacotherapy in Type 1 Diabetes Chapter 12 Angela McGibbon, Cindy Richardson, Cheri Hernandez,
Paediatric Diabetes Nurses October 2013 Diabetes Update.
Staff Training Presentation Diabetes Education & Camping Association.
INSULIN STRATEGIES IN TYPE 2 DIABETES. The epidemic of type 2 diabetes and the recognition that achieving specific glycemic goals can substantially reduce.
1-800-DIABETES DIABETES CARE TASKS AT SCHOOL: What Key Personnel Need to Know DIABETES CARE TASKS AT SCHOOL: What Key Personnel Need to.
Insulin therapy.
Insulin Prescribing.
Case Studies on Insulin Initiation
INSULIN THERAPY IN TYPE 1 DIABETES
Hypoglycaemia Diabetes Outreach (June 2011). 2 Hypoglycaemia Learning outcomes >Can state what hypoglycaemia is >Be able to assess who is at risk of hypoglycaemia.
Module 3 Initial Recognition, Triaging, and Management of Hyperglycemia Diabetes Special Interest Group Georgia Hospital Association.
Basal and Meal Time Insulin Case Study
Inpatient Glycemic Management
Insulin Glargine (Lantus) Lantus is a long-acting insulin that should be injected below the skin once daily as directed by your doctor. Take Lantus the.
Insulin Initiation In Primary Care Dr Arla Ogilvie Endocrinologist Watford General Hospital West Herts Hospitals NHS Trust.
Hypoglycemia & Hyperglycemia Dave Joffe, BSPharm, CDE, FACA Part 2.
INSULIN PUMPS Shelby Polk DNP, FNP-BC, CDE. 2 MANAGEMENT OF DIABETES IN SCHOOLS Exercise Legal Rights Health & Learning Nutrition Insulin Administration.
Insulins Roland Halil, BScPharm, ACPR, PharmD Clinical Pharmacist, Bruyere Academic Family Health Team Assistant Professor, Dept of Family Medicine, U.
 Provide a high level overview of diabetes head to toe.  Discuss the importance of keeping A1Cs under 8.  Identify ways to prevent long-term complications.
Source:
Diabetes Update: Michael Gottschalk, M.D, Ph.D.
ADDITIONAL SLIDES FOR ASSIST WITH COMPREHENSION OF LAB CONTENT-MODULE FIVE-DM DENISE TURNER, MS-N.ED, RN, CCRN.
Insulin initiation in Type 2 Diabetes
What Key Personal Need To Know INSULIN ADMINISTRATION.
Diabetes Mellitus Part 2 Kathy Martin DNP, RN, CNE.
Lesson One Cabin/ Archery Station (Vocabulary). Doctor’s Video What is Type-1 Diabetes What causes Type-1 Diabetes What are the symptoms How is it diagnosed.
Introduction Subcutaneous insulin absorption is not reproducible and insulin entry directly into the circulation is not linked to glucose sensing Basal.
Help with Hypos Vera Nagle Diabetes Nurse Specialist Practice Nurse Conference 1/10/16.
Quality of Life Matters NOT TOO HIGH… NOT TOO LOW… A PLAN FOR OPTIMIZING DIABETES MANAGEMENT IN NURSING HOMES 5. Insulin: Part 1.
Hypo and Hyperglycemia
Insulins Roland Halil, BScPharm, ACPR, PharmD
Insulin Type (trade name)
Jill Little Diabetes Specialist Nurse
Pharmacy Protocol for Insulin Dosing in the Hospitalized Patient
Insulins Roland Halil, BScPharm, ACPR, PharmD
Alisa Foote SDSU School of Nursing 10/14/11.
Insulins Roland Halil, BScPharm, ACPR, PharmD
Karen McAvoy RN, MSN, CDE Joslin Diabetes Center
Endocrine System KNH 411.
Diabetes Jessica Tagerman PharmD
Endocrine System KNH 411.
Jill Little Diabetes Specialist Nurse
Presented By: Sumia Khan
Insulin Safety know your insulins! There are many! Humalog® Mix25 Humalog® Mix50 Humulin® I Humulin® M3 Humulin® S Humalog® U-100 Humalog® U-200.
T1DM: Insulin Initiation
Diabetes.
Endocrine System KNH 411.
Treatment Pathway for Adults with Type 1 Diabetes
Approach to starting and adjusting insulin in type 2 diabetes.
Glycemic Management in Adults with Type 1 Diabetes
Managing Hypoglycemia & Hyperglycemia
Diabetes Specialist Nurses
Endocrine System KNH 411.
Endocrine System KNH 411.
Endocrine System KNH 411.
Diabetes Source: Medicine Issue Date: 12/2010
INSULINS Dr.R.Sajjad december INSULINS Dr.R.Sajjad december 2018.
Insulin Delivery Systems Atlanta Diabetes Associates
Inpatient Insulin Management on the Wards
Insulin in Type 2 Diabetes
CPPE Optimise: Insulins
MANDATORY INSULIN EDUCATION
Presentation transcript:

Innovations in Insulin Joanne Reid RN CDE jmreid@gbhs.on.ca Danielle Benedict RPh

Outline… Setting the stage Insulin as pancreas replacement therapy Commonly used insulins New insulins Case Studies Dosing information Hypoglycemia 4 Essential skills for giving insulin Questions? Pumping is simply an extension of insulin delivery options

What is Diabetes & What does insulin do? Pathophysiology reminder… What does insulin do? Setting the Stage What is Diabetes & What does insulin do?

Types of Diabetes Type 2 is at least a ‘dual’ diagnosis diagnosed when insulin production is dwindling because of insulin resistance accounts for 80-90% of all diabetes is the main media and government funding focus Management includes treating insulin resistance (ie Metformin) and treating insulin deficiency (ie Diamicron MR or insulin) treated with lifestyle measures, oral &/or injectible medications

Types of Diabetes Gestational may happen during pregnancy where significant insulin resistance is present the woman and her baby will have increased risk of developing Type 2 Diabetes later in life treated with lifestyle measures, oral medications &/or insulin

Types of Diabetes Type 1 The pancreas does not produce the insulin needed to give the body life sustaining energy. treated with insulin

or Augmentation Therapy Insulin is Pancreas Replacement or Augmentation Therapy

What does a PANCREAS do anyway? Important to note: everyone’s pancreas adjusts insulin daily to meet their needs. With Type 1 diabetes, you are no different. You should get varying amounts of insulin each day according to your body’s needs. The neat thing about pumping is that you give insulin to food and not food to insulin

Current Best Practice Basal / Bolus Theory The healthy pancreas produces some insulin 24 hrs/day to support the energy for basal body functions – to make the heart beat and the brain think. It also produces insulin in response to blood glucose rises related to food intake, stress, illness, some medications, excitement, growth hormone etc. – more like boluses of insulin. Therefore, insulin therapy should ensure both of these needs for insulin are being met.

Insulin + Sugar = ENERGY ‘Nice & Simple !!’ eh? Insulin + Sugar = ENERGY

Insulin categories Long Acting ‘Basal’ insulins Short or Rapid Acting meal or ‘Bolus’ insulins Premixed - a mixture of basal and bolus insulins Danielle starts

Basal Insulin Longer acting insulin is used for ‘basal’ coverage. Glargine (Lantus) Detemir (Levemir) or NPH (Humulin N or Novolin NPH)

The healthy pancreas

The healthy pancreas / Time-action profile of NPH

The healthy pancreas / Time-action profile of NPH and Levemir®

Bolus Insulin A short or most commonly ‘rapid’ acting insulin is used with meals and sometimes snacks as a ‘bolus’ insulin. Lispro (Humalog) Aspart (NovoRapid) Glulisine (Apidra)

The healthy pancreas

Time-action profile of regular insulin

Time-action profile of Rapid acting inuslins (NovoRapid, Humalog, Apidra)

Basal-bolus analogue therapy

Premixed Insulin A short or most commonly ‘rapid’ acting insulin is mixed with intermediate acting insulin and used 2 or sometimes 3 x’s daily with meals. Humalog Mix 25, Humalog Mix 50 NovoMix 30 (The number represents the % of the mix that is rapid acting insulin. The remaining will be intermediate acting insulin.)

The healthy pancreas

Time-action profile of Novolin® ge 30/70 (older premix, leaves risk of hypoglycemia)

Humalog Mix 25 (Lilly) Newer ‘ANALOGUE’ Premixed

Humalog Mix 50 (Lilly)

Commonly Used Insulins

Insulin Overview – Action Profile

Commonly Used Insulins human insulins analogue isnulins basal Novolin NPH Humulin N - Shake well Glargine/Basaglar (Lantus) Toujeo is U300 lantus Detemir (Levemir) bolus Novolin Toronto Humulin R -best reserved for use in IV’s Aspart (NovoRapid) Lispro (Humalog) Humalog U200 kwikpen Glulisine (Apidra) **must be taken WITH food** premix Novolin or Humulin 30/70 30% bolus or regular; 70% basal or NPH NovoMix 30 HumalogMix 25 Humalog Mix 50 # indicates the % of bolus or rapid insulin; the rest is basal or NPH-like - Shake well This slide is intended as a comprehensive reference.

New insulins U200 & U300 are new, more concentrated formulations of insulin New insulin actions – one faster, one longer Pen demos

New insulin formulations Until recently all insulins were ‘U100’ Which is a concentration of 100 units/mL Toujeo U300 and Humalog U200 are more concentrated forms of insulin. What does this mean to the patient?

Lantus vs Toujeo Never draw into a syringe !

Lantus vs Toujeo

Humalog family of insulins

New Insulin actions (NovoNordisk) Fiasp = Faster acting insulin aspart & coming soon Degludec (Tresbia) = Ultra Long acting basal insulin

Fiasp – a more ideal bolus/meal insulin Faster initial absorption Aiming for improved glycemic control after a meal For tx of people with type 1 and type 2 Distribution in Canada as of Jan.2017

What is a more ideal basal insulin? Has a physiological, flat time–action profile Has a low risk of hypoglycaemia Has a long duration of action (more than 24 hours) Controls fasting glucose with one daily injection Has a predictable metabolic effect

Degludec (Tresbia) provides uniform "peakless" action extends over more than 24 hours ½ life of ~ 24 hrs; duration of action ~42 hrs highly consistent from dose to dose Will be available in 2 concentrations: 200 Units/mL in a FlexTouch prefilled pen – likely used for most people with type 2 diabetes 100 Units/mL cartridges to be used in a NovoPen by patients requiring small basal insulin doses, including most patients with type 1 diabetes

Degludec Not yet available in Canada; on the world market since ~2013

Case Studies

Case Study # 1 – Insulin adjustment 90 yr. old female with Type 2 Diabetes residing in a nursing home Rx Lantus – start at 10 units hs and increase 2 units/day until fasting BG is 5-7mmol/L Joanne starts

Case Study # 1 – Insulin adjustment Now on 14 units qhs - FBS 4.5mmol/L You are the nurse; do you… Hold the insulin? Reduce the dose? Call the community pharmacist or the doctor? Cross your fingers? Do an extra blood sugar check in the night? Give the patient an extra snack? Give the insulin as ordered?

Case Study # 1 - Solved You can reduce a dose for the safety of avoiding low blood sugar and then get order the next day. (Document the rationale.) Holding the dose can cause more harm than reducing the dose Give the dose, give the patient an extra snack and do an extra blood sugar check in the night? (Document the rationale.) Acknowledge the … double checking doses vs patient adjustment. Space between self-adjustment and dr. order.

Case Study # 2 – How much is too much? 57 yr. old male, 10 yr hx T2D, 115 kg Rx Lantus – start at 20 units hs and increase 2 units/day until fasting BG is 5-7 mmol/L In 3 months, the patient is on 100 units with FBG of 8-10 mmo/L Sweetened beverages – coping Home vs hosp

Case Study # 2 – How much is too much? Things to consider… Consider low BG’s – night eating How often is he monitoring? What is night snack? Is it different? What does he drink for thirst? Was ‘control’ established in hosp.? Food, activity & well-being may have changed Review all medication change/adherence

Case Study # 2 - Solved He is very close to 1 Unit/Kg of basal insulin alone – we will discuss the implications of this shortly We haven’t given A1c information When teaching self-adjustment of insulin, I try to give people an educated, but arbitrary ‘limit’ before consulting & reviewing total therapy

What is a ‘Typical’ Dose of Insulin? Dosing Information What is a ‘Typical’ Dose of Insulin?

What is a ‘Typical’ Dose of Insulin? Have you ever been concerned that an ordered insulin dose was too high or too low? Important notes on the differences between Type 1 and Type 2 diabetes

People with Type 2 diabetes Usually have some endogenous insulin Often do not become metabolically unstable if medications are stopped in the short term; this may impede healing/recovery Often have significant insulin resistance and therefore take larger doses of insulin Prize for the person who knows about HHNK - hyperglycemic, hyperosmolar, non-ketotic coma

People with Type 1 diabetes Do not have endogenous insulin Insulin omission will promptly result in metabolic decompensation Are usually quite insulin sensitive and therefore smaller doses of insulin will have more of an effect than you might expect

Insulin sensitivity affects insulin dosing and accounts for the dramatic difference in insulin doses for patients with Type 1 vs Type 2 diabetes.

Some examples of reasonable insulin dosing Type 1 Type 2 2 patients 65 Kg female 90 Kg female Usual range of insulin/Kg body weight 0.5-0.7 U/Kg 1 – 2 U/Kg Basal insulin 16 – 22 U daily 45 – 90 U daily Bolus insulin 5 – 8 U TID ac 15–30 U TID ac Promise to allow practice in the next section

Insulin sensitivity affects insulin dosing Type 1 Type 2 2 patients 110 Kg male Usual range of insulin/Kg body weight 0.5-0.7 U/Kg 1 – 2 U/Kg Basal insulin 28– 40 U daily 55 – 110 U daily Bolus insulin 9 – 13 U TID ac 18 - 37 U TID ac

Insulin Using Type 1 vs Type 2 No endogenous insulin Very insulin sensitive Type 2 Often has some endogenous insulin May be very resistant to insulin Body weight can be a deceiving indicator of Type 1 vs Type 2 diabetes.

Hypoglycemia Low Blood Sugar

HYPOGLYCEMIA = Low Blood Sugar People are in crisis Stay with them until treatment and recovery are complete S & sx -- Sweaty, shaky, trembling, nervous restless, irritable, spacey, pale, inappropriate confusion is a potential side effect of all insulin regimens (& some orals too!)

3 tsp. or 15 gms of SUGAR 1st When feeling better or 4 candies or 3/4 cup juice or 3/4 cup regular pop Wait 15 min. with the person !!!!!!!!!! Retreat with SUGAR as necessary !!!!!!!! When feeling better or Blood sugar is rising and above 4 Then and ONLY THEN, follow with a snack of ~ 15 gms of carbohydrate 2-3 plain cookies granola bar Carry these items at ALL times Put them in your car, backpack & pockets.

4 Essential skills for giving insulin Supporting Clients on Insulin - the ESSENTIALS

Supporting Clients on Insulin - the ESSENTIALS To give insulin the client needs to know… How to give insulin How to monitor blood sugars How to treat low blood sugar Basic information about food To support clients on insulin, you may want to be familiar with their meter usual symptoms and treatments for low blood sugars

Never underestimate the effect of injection site rotation NB: Never underestimate the effect of injection site rotation

Questions? Refer to the ‘Clinical Practice Guidelines for the Management of Diabetes in Canada’ current version. found online @ http://www.diabetes.ca/